77 related articles for article (PubMed ID: 5583430)
1. Time course of 3H-reserpine levels in brains of normal and tetrabenzine-prenetrated rats.
Manara L; Garattini S
Eur J Pharmacol; 1967 Nov; 2(2):139-41. PubMed ID: 5583430
[No Abstract] [Full Text] [Related]
2. Sensitivities of the brains of infant and adult rats to the catecholamine-depleting actions of reserpine and tetrabenazine.
Kulkarni AS; Shideman FE
J Pharmacol Exp Ther; 1966 Sep; 153(3):428-33. PubMed ID: 5922320
[No Abstract] [Full Text] [Related]
3. Regional distribution of persistently bound reserpine in rat brain.
Enna SJ; Shore PA
Biochem Pharmacol; 1971 Oct; 20(10):2910-2. PubMed ID: 5114522
[No Abstract] [Full Text] [Related]
4. Specific binding of reserpine. Association with norepinephrine depletion.
Alpers HS; Shore PA
Biochem Pharmacol; 1969 Jun; 18(6):1363-72. PubMed ID: 5799110
[No Abstract] [Full Text] [Related]
5. Identification of nonserotonergic [3H]ketanserin binding sites associated with nerve terminals in rat brain and with platelets; relation with release of biogenic amine metabolites induced by ketanserin- and tetrabenazine-like drugs.
Leysen JE; Eens A; Gommeren W; van Gompel P; Wynants J; Janssen PA
J Pharmacol Exp Ther; 1988 Jan; 244(1):310-21. PubMed ID: 3336007
[TBL] [Abstract][Full Text] [Related]
6. Influence of reserpine, tetrabenzine and iproniazid on self-stimulation by rats.
Haley TJ; Flesher AM; Komesu N
Arch Int Pharmacodyn Ther; 1968 Jan; 171(1):198-205. PubMed ID: 5646015
[No Abstract] [Full Text] [Related]
7. The relation between the subcellular distribution of [3H]resperpine and its proposed site of action.
Wagner LA; Stitzel RE
J Pharm Pharmacol; 1972 May; 24(5):396-402. PubMed ID: 4403810
[No Abstract] [Full Text] [Related]
8. 3H-reserpine persistently bound "in vivo" to rat brain subcellular components: limited removal by peanut oil extraction.
Manara L; Mennini T; Cerletti C
Life Sci; 1974 Jun; 14(11):2267-76. PubMed ID: 4847816
[No Abstract] [Full Text] [Related]
9. Tetrabenazine, an amine-depleting drug, also blocks dopamine receptors in rat brain.
Reches A; Burke RE; Kuhn CM; Hassan MN; Jackson VR; Fahn S
J Pharmacol Exp Ther; 1983 Jun; 225(3):515-21. PubMed ID: 6864517
[TBL] [Abstract][Full Text] [Related]
10. Action of reserpine in morphine-tolerant rats: absence of an antagonism of catecholamine depletion.
Blosser JC; Catravas GN
J Pharmacol Exp Ther; 1974 Nov; 191(2):284-9. PubMed ID: 4422904
[No Abstract] [Full Text] [Related]
11. Autoradiographic localization of [3H]reserpine binding sites in rat brain.
Murrin LC; Enna SJ; Kuhar MJ
J Pharmacol Exp Ther; 1977 Dec; 203(3):564-74. PubMed ID: 925958
[TBL] [Abstract][Full Text] [Related]
12. Recovery of a discriminated lever-press avoidance performance from the effects of reserpine, chlorpromazine and tetrabenazine.
Levison PK; Freedman DX
Arch Int Pharmacodyn Ther; 1967 Nov; 170(1):31-8. PubMed ID: 6056591
[No Abstract] [Full Text] [Related]
13. In vivo persistent binding of 3 H-reserpine to rat brain subcellular components.
Manara L; Carminati P; Mennini T
Eur J Pharmacol; 1972 Oct; 20(1):109-13. PubMed ID: 4637936
[No Abstract] [Full Text] [Related]
14. Functional molecular mass of binding sites for [3H]dihydrotetrabenazine and [3H]reserpine and of dopamine beta-hydroxylase and cytochrome b561 from chromaffin granule membrane as determined by radiation inactivation.
Gasnier B; Ellory JC; Henry JP
Eur J Biochem; 1987 May; 165(1):73-8. PubMed ID: 3569299
[TBL] [Abstract][Full Text] [Related]
15. Effect of desmethylimipramine, protriptyline and (+)-amphetamine on fluorescence of central adrenergic neurons of rats pretreated with alpha-methyl-DOPA and tetrabenazine or reserpine.
Carlsson A; Fuxe K; Hökfelt T
Eur J Pharmacol; 1967 Dec; 2(3):196-201. PubMed ID: 5590343
[No Abstract] [Full Text] [Related]
16. Incorporation of reserpine into isolated rat peritoneal mast cells and mast cell granules in vitro.
Gripenberg J; Jansson SE; Partanen T
Acta Physiol Scand; 1972 Dec; 86(4):433-43. PubMed ID: 4640282
[No Abstract] [Full Text] [Related]
17. [Comparison of tetrahydropalmatine, tetrabenazine and reserpine in monoamine depleting action].
Liu GQ; Ma ZQ
Yao Xue Xue Bao; 1988; 23(10):721-6. PubMed ID: 2476908
[No Abstract] [Full Text] [Related]
18. Brain 5-hydroxytryptamine and anterior pituitary activation by reserpine and its analogs.
Dixit BN
Arch Int Pharmacodyn Ther; 1971 Jan; 189(1):100-8. PubMed ID: 4256999
[No Abstract] [Full Text] [Related]
19. The fate of tritium-labeled reserpine in the chick embryo: a preliminary report.
Dahl AL; Giacobini E; Serra G; Manara L
J Neurosci Res; 1980; 5(1):73-8. PubMed ID: 6103965
[TBL] [Abstract][Full Text] [Related]
20. Differential interactions of phencyclidine with tetrabenazine and reserpine affecting intraneuronal dopamine.
Bagchi SP
Biochem Pharmacol; 1983 Oct; 32(19):2851-6. PubMed ID: 6626259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
